Caffey disease or infantile cortical hyperostosis: a case report
Narayanan Kutty1, Doylene Thomas, Lionel George
1Department of Child Health, Sultan Qaboos Hospital, Salalah, Sultanate of Oman.
Oman Medical Journal
|November 30, 2011
Summary
Caffey disease, also known as Infantile Cortical Hyperostosis (ICH), is a rare infant condition causing bone inflammation and systemic symptoms. Early diagnosis is crucial as it can mimic other serious illnesses.
Area of Science:
- Pediatric medicine
- Skeletal biology
- Rare diseases
Background:
- Infantile Cortical Hyperostosis (ICH), or Caffey disease, is a rare, self-limiting condition primarily affecting infants.
- It presents with acute periosteal inflammation, soft tissue swelling, irritability, and fever.
Observation:
- Diagnosis can be challenging due to overlapping symptoms with osteomyelitis, hypervitaminosis A, scurvy, bone tumors, and child abuse.
- The condition involves characteristic bone changes that aid in diagnosis.
Findings:
- Caffey disease is characterized by subperiosteal new bone formation.
- Systemic symptoms like fever and irritability are common accompanying features.
Implications:
- Raising clinician awareness of Caffey disease is vital for timely and accurate diagnosis.
- Distinguishing ICH from other pediatric conditions prevents unnecessary investigations and treatments.
More Related Videos
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:19Cerebral Edema l: Introduction
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...